Literature DB >> 12904848

Acute community-acquired bacterial meningitis in adults admitted to the intensive care unit: clinical manifestations, management and prognostic factors.

Juan M Flores-Cordero1, Rosario Amaya-Villar, Maria D Rincón-Ferrari, Santiago R Leal-Noval, José Garnacho-Montero, Ana C Llanos-Rodríguez, Francisco Murillo-Cabezas.   

Abstract

OBJECTIVE: To study the clinical features, management and prognostic factors associated with adverse clinical outcome in a series of patients with acute community-acquired bacterial meningitis admitted to the intensive care unit (ICU). DESIGN AND
SETTING: Descriptive, prospective study at two ICUs of a university hospital over a 6-year period. PATIENTS: Sixty-four episodes in 62 adults with acute community-acquired bacterial meningitis admitted to the ICU.
RESULTS: Most of the patients (95.3%) were admitted to the ICU presenting with altered mental status (the median value of Glasgow Coma Scale (GCS) was 11). Overall mortality rate was 10.9% (7 patients) and 11 (17.1%) developed adverse clinical outcome (death or severe neurologic deficit). The features associated with adverse clinical outcome were: age over 50 years, seizures or focal neurologic signs at admission, a GCS score of 10 or less and an APACHE II score more than 13 at admission to the ICU. Only the severity of the disease determined according to the APACHE II scale was independently associated with adverse clinical outcome after a multivariate analysis was performed (adjusted odds ratio =8.74; 95% CI =1.70-44.77; p=0.009). All patients were empirically treated with third-generation cephalosporins and dexamethasone was used in 40 cases (62.5%). Ten patients (15.6%) received mannitol, nine of them after a transcranial Doppler sonography recording had been performed.
CONCLUSIONS: In adult patients with acute community-acquired bacterial meningitis admitted to the ICU, the overall severity of the disease within 24 h of admission may be the major indicator of adverse in-hospital clinical outcome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12904848     DOI: 10.1007/s00134-003-1935-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   41.787


  27 in total

1.  Bacterial meningitis in Malawian adults: pneumococcal disease is common, severe, and seasonal.

Authors:  S B Gordon; A L Walsh; M Chaponda; M A Gordon; D Soko; M Mbwvinji; M E Molyneux; R C Read
Journal:  Clin Infect Dis       Date:  2000-07-11       Impact factor: 9.079

2.  A 20-year epidemiological study of pneumococcal meningitis.

Authors:  R J Stanek; M A Mufson
Journal:  Clin Infect Dis       Date:  1999-06       Impact factor: 9.079

Review 3.  Transcranial Doppler ultrasonography in the neurocritical care unit.

Authors:  E M Manno
Journal:  Crit Care Clin       Date:  1997-01       Impact factor: 3.598

4.  Assessment of coma and impaired consciousness. A practical scale.

Authors:  G Teasdale; B Jennett
Journal:  Lancet       Date:  1974-07-13       Impact factor: 79.321

5.  Dexamethasone in adults with bacterial meningitis.

Authors:  Jan de Gans; Diederik van de Beek
Journal:  N Engl J Med       Date:  2002-11-14       Impact factor: 91.245

6.  Relationship between short-term outcome and occurrence of cerebral artery stenosis in survivors of bacterial meningitis.

Authors:  M Müller; S Merkelbach; M Hermes; J König; K Schimrigk
Journal:  J Neurol       Date:  1998-02       Impact factor: 4.849

7.  Bacterial meningitis in the United States in 1995. Active Surveillance Team.

Authors:  A Schuchat; K Robinson; J D Wenger; L H Harrison; M Farley; A L Reingold; L Lefkowitz; B A Perkins
Journal:  N Engl J Med       Date:  1997-10-02       Impact factor: 91.245

8.  Pneumococcal meningitis in the intensive care unit: prognostic factors of clinical outcome in a series of 80 cases.

Authors:  Marc Auburtin; Raphaël Porcher; Fabrice Bruneel; Agnès Scanvic; Jean Louis Trouillet; Jean Pierre Bédos; Bernard Régnier; Michel Wolff
Journal:  Am J Respir Crit Care Med       Date:  2002-03-01       Impact factor: 21.405

9.  Acute bacterial meningitis in adults. A review of 493 episodes.

Authors:  M L Durand; S B Calderwood; D J Weber; S I Miller; F S Southwick; V S Caviness; M N Swartz
Journal:  N Engl J Med       Date:  1993-01-07       Impact factor: 91.245

10.  Clinical relevance and frequency of transient stenoses of the middle and anterior cerebral arteries in bacterial meningitis.

Authors:  M Müller; S Merkelbach; G P Huss; K Schimrigk
Journal:  Stroke       Date:  1995-08       Impact factor: 7.914

View more
  31 in total

Review 1.  Year in review in Intensive Care Medicine-2003. Part 1: Respiratory failure, infection and sepsis.

Authors:  Edward Abraham; Peter Andrews; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Michael Pinsky; Peter Radermacher; Marco Ranieri; Christian Richard; Robert Tasker; Benoît Vallet
Journal:  Intensive Care Med       Date:  2004-05-15       Impact factor: 17.440

2.  Accuracy of clinical presentation for differentiating bacterial from viral meningitis in adults: a multivariate approach.

Authors:  François G Brivet; Sophie Ducuing; Frédéric Jacobs; Isabelle Chary; Roger Pompier; Dominique Prat; Bogdan D Grigoriu; Patrice Nordmann
Journal:  Intensive Care Med       Date:  2005-10-22       Impact factor: 17.440

3.  Prognostic factors in adult community-acquired bacterial meningitis: a 4-year retrospective study.

Authors:  F A Dauchy; D Gruson; G Chêne; J Viot; C Bebear; J Maugein; M C Bézian; H Dutronc; M Dupon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10       Impact factor: 3.267

Review 4.  Recommendations on the use of EEG monitoring in critically ill patients: consensus statement from the neurointensive care section of the ESICM.

Authors:  Jan Claassen; Fabio S Taccone; Peter Horn; Martin Holtkamp; Nino Stocchetti; Mauro Oddo
Journal:  Intensive Care Med       Date:  2013-05-08       Impact factor: 17.440

5.  Therapeutic hypothermia for adult viral meningoencephalitis.

Authors:  Marko Kutleša; Bruno Baršić; Dragan Lepur
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

6.  Bedside evaluation of cerebral energy metabolism in severe community-acquired bacterial meningitis.

Authors:  Frantz R Poulsen; Mette Schulz; Anne Jacobsen; Åse B Andersen; Lykke Larsen; Wilhelm Schalén; Troels H Nielsen; Carl-Henrik Nordström
Journal:  Neurocrit Care       Date:  2015-04       Impact factor: 3.210

7.  Dexamethasone for adult community-acquired bacterial meningitis: 20 years of experience in daily practice.

Authors:  Vjerislav Peterković; Vladimir Trkulja; Marko Kutleša; Vladimir Krajinović; Dragan Lepur
Journal:  J Neurol       Date:  2011-06-25       Impact factor: 4.849

Review 8.  Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options.

Authors:  Françoise Van Bambeke; René R Reinert; Peter C Appelbaum; Paul M Tulkens; Willy E Peetermans
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  Three-year multicenter surveillance of community-acquired Listeria monocytogenes meningitis in adults.

Authors:  Rosario Amaya-Villar; Emilio García-Cabrera; Elena Sulleiro-Igual; Pedro Fernández-Viladrich; Dionisi Fontanals-Aymerich; Pilar Catalán-Alonso; Carlos Rodrigo-Gonzalo de Liria; Ana Coloma-Conde; Fabio Grill-Díaz; Antonio Guerrero-Espejo; Jerónimo Pachón; Guillén Prats-Pastor
Journal:  BMC Infect Dis       Date:  2010-11-11       Impact factor: 3.090

10.  Neurocritical care of patients with central nervous system infections.

Authors:  Andreas H Kramer; Thomas P Bleck
Journal:  Curr Treat Options Neurol       Date:  2008-05       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.